Simcere Surpi eval project

Investigator: Charles Chiu, MD, PhD
Sponsor: Simcere Diagnostics Co., Ltd

Location(s): United States


SURPI (“Sequence-Based Ultra-Rapid Pathogen Identification”) is a computational pipeline for pathogen identification from complex metagenomic next-generation sequencing (NGS) data. Metagenomic sequencing of clinical samples for pathogen detection has numerous applications for public health surveillance, outbreak investigation, and the diagnosis of infectious diseases. However, practical deployment of the technology has been hindered by the bioinformatics challenge of analyzing results accurately and in a clinically relevant timeframe. SURPI was developed to address these challenges.